VALDUCCI; Roberto

Patent Applications and Registrations

Patent applications and USPTO patent grants for VALDUCCI; Roberto.The latest application filed is for "formulation for oral administration containing mesalazine".

Company Profile

0.6.14

VALDUCCI; Roberto - Savignano Sul Rubicone IT
Valducci; Roberto - Savignano sul Rubicone FC
Valducci; Roberto - 47029 Savignano Sul Rubicone Forli'
Valducci; Roberto - Paderno Dugnano IT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Formulation For Oral Administration Containing Mesalazine App 20170143743 - VALDUCCI; Roberto ; et al.	2017-05-25
A Modified-release Oral Pharmaceutical Formulation Containing Gliclazide App 20160158196 - VALDUCCI; Roberto ; et al.	2016-06-09
Formulations For The Preparation Of Immediate-release Tablets For Oral Use Containing Low-dose Mifepristone For The Treatment Of Endometriosis, Tablets Thus Obtained And Their Preparation Process App 20150164917 - Valducci; Roberto ; et al.	2015-06-18
Formulations For The Preparation Of Immediate Release Tablets For Oral Administration Containing Low-dose Mifepristone, Tablets Thus Obtained And Their Preparation Process App 20150148324 - Valducci; Roberto ; et al.	2015-05-28
Pharmaceutical Formulations For The Oral Administration Of Ppi App 20110045068 - Valducci; Roberto ; et al.	2011-02-24
Pharmaceutical composition for the oral administration of omega polyenoic fatty acids and one or more active principles incompatible therewith, and a process for its preparation App 20100310650 - Valducci; Roberto	2010-12-09
Controlled Release Pharmaceutical Composition of Venlafaxine Hydrochloride, and Process for Preparation Thereof App 20090263471 - Valducci; Roberto ; et al.	2009-10-22
Modified Release Formulation of Lithium Carbonate and Method for Preparation Thereof App 20070148253 - Valducci; Roberto ; et al.	2007-06-28
Oral solid pharmaceutical formulations with pH-dependent multiphasic release Grant 7,022,345 - Valducci April 4, 2	2006-04-04
Multiparticulate formulations of lithium salts for oral administration suitable for once-a-day administration App 20060039997 - Valducci; Roberto ; et al.	2006-02-23
Multiparticulate formulations of lithium salts for oral administration suitable for once-a-day administration Grant 6,994,873 - Valducci , et al. February 7, 2	2006-02-07
Use of chloroquine, hydroxychloroquine and 4 amino-quinolinic derivatives to obtain a drug for the anti retroviral therapy, active towards HIV sensitive strains and towards HIV strains which are resistant to both nucleosidic and non-nucleosidic reverse transcriptase inhibitors and to proteases inhib App 20040006103 - Valducci, Roberto ; et al.	2004-01-08
Multiparticulate enteric coated and multiparticulate enteric coated prolonged release formulations containing NADH App 20030181414 - Valducci, Roberto ; et al.	2003-09-25
Modified release pharmaceutical composition containing bupropion HCI as active substance App 20030134906 - Valducci, Roberto ; et al.	2003-07-17
Multiparticulate formulations of lithium salts for oral administration suitable for once-a-day administration App 20020172727 - Valducci, Roberto	2002-11-21
Oral solid pharmaceutical formulations with pH-dependent multiphasic release App 20020034541 - Valducci, Roberto	2002-03-21
Controlled release pharmaceutical compositions for the oral administration containing nifedipine as active substance Grant 5,871,775 - Valducci February 16, 1	1999-02-16
Pharmaceutical oral controlled release composition comprising small pellets of bile acids Grant 5,422,124 - Valducci June 6, 1	1995-06-06
Coating membrane and compositions prepared therefrom Grant 5,149,542 - Valducci September 22, 1	1992-09-22
Apparatus For Laboratory Testing Of Sustained Release Drugs Grant 3,742,190 - Giani , et al. June 26, 1	1973-06-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.